
- Hepatitis C
- Primary sclerosing cholangitis
- Cirrhosis
- Liver Transplantation
- Clinical Trials
- Healthcare disparities in liver disease
- Outcomes Research
Education and Training
- Fellow in Gastroenterology, Medicine, Duke University, 1998 - 2000
- Chief Medical Resident, Medicine, Duke University, 1997 - 1998
- Fellow in Gastroenterology, Medicine, Duke University, 1996 - 1997
- Medical Resident, Medicine, Duke University, 1993 - 1996
- M.H.S., Duke University, 2001
- M.D., Duke University, 1993
Grants
- GS-US-428-4194
- A randomized, double-blind, dose-ranging, placebo-controlled, Phase 2a evaluation of the safety, tolerability, and pharmacokinetics of PLN-74809 in participants with primary sclerosing cholangitis (PSC) and suspected liver fibrosis (INTEGRIS-PSC)
- CymaBay CB8025-31735
- Novartis - AMBER - VAY736
- Medical Student Research Training Supplement
- T32-Diversity: NRSA Diversity Supplement Award
- Abbreviated MRI for HCC screening in cirrhotic patients
- HBV Clinical Research Network Site Application_Subcontract to UNC